-
1دورية أكاديمية
المؤلفون: Chandrakant P Suryawanshi, Dr. R. D. Wagh
مصطلحات موضوعية: Anthracene, Parkinson's Ailment, Oxotremorine, Tremor, Procyclidine
العلاقة: https://zenodo.org/communities/iajprTest; https://zenodo.org/record/7686984Test; https://doi.org/10.5281/zenodo.7686984Test; oai:zenodo.org:7686984
الإتاحة: https://doi.org/10.5281/zenodo.7686984Test
https://doi.org/10.5281/zenodo.7686983Test
https://zenodo.org/record/7686984Test -
2دورية أكاديمية
المؤلفون: Scordino, Miriana, Frinchi, Monica, Urone, Giulia, Nuzzo, Domenico, Mudo, Giuseppa, Di Liberto, Valentina
المساهمون: Scordino, Miriana, Frinchi, Monica, Urone, Giulia, Nuzzo, Domenico, Mudo, Giuseppa, Di Liberto, Valentina
مصطلحات موضوعية: oxotremorine, superoxide dismutase, muscarinic acetylcholine receptor, KNK437, neuroprotection, heat shock protein
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36978935; info:eu-repo/semantics/altIdentifier/wos/WOS:000952904100001; volume:12; issue:3; firstpage:1; lastpage:17; numberofpages:17; journal:ANTIOXIDANTS; https://hdl.handle.net/10447/590711Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85151371751; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045076Test/
الإتاحة: https://doi.org/10.3390/antiox12030687Test
https://hdl.handle.net/10447/590711Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045076Test/ -
3دورية أكاديمية
المؤلفون: Miriana Scordino, Monica Frinchi, Giulia Urone, Domenico Nuzzo, Giuseppa Mudò, Valentina Di Liberto
المصدر: Antioxidants; Volume 12; Issue 3; Pages: 687
مصطلحات موضوعية: oxotremorine, muscarinic acetylcholine receptor, KNK437, neuroprotection, heat shock proteins, superoxide dismutase
جغرافية الموضوع: agris
وصف الملف: application/pdf
-
4دورية أكاديمية
المؤلفون: Hu, Li, He, Fengli, Huang, Meifeng, Zhao, Qian, Cheng, Lamei, Said, Neveen, Zhou, Zhiguang, Liu, Feng, Dai, Yan-Shan
المصدر: Scientific Reports; 10/16/2020, Vol. 10 Issue 1, p1-10, 10p
مصطلحات موضوعية: INSULIN, GLUCOSE, OXOTREMORINE, MUSCARINIC receptors, PHOSPHATIDYLINOSITOL 3-kinases
-
5دورية أكاديمية
المؤلفون: Volpato, Daniela, Kauk, Michael, Messerer, Regina, Bermudez, Marcel, Wolber, Gerhard, Bock, Andreas, Hoffmann, Carsten, Holzgrabe, Ulrike
مصطلحات موضوعية: allosteric modulators, acetylcholine-receptors, molecular-mechanisms, alzheimers-disease, agonist, binding, site, oxotremorine, ddc:570
وصف الملف: 10 Seiten; application/pdf
العلاقة: https://refubium.fu-berlin.de/handle/fub188/29529Test; http://dx.doi.org/10.17169/refubium-29273Test
الإتاحة: https://doi.org/10.17169/refubium-29273Test
https://doi.org/10.1021/acsomega.0c04220Test
https://refubium.fu-berlin.de/handle/fub188/29529Test -
6دورية أكاديمية
المصدر: Frontiers in Pharmacology, Vol 10 (2019)
مصطلحات موضوعية: M4 muscarinic receptor, biorhythm, motor activity, temperature, scopolamine, oxotremorine, Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/article/10.3389/fphar.2019.00237/fullTest; https://doaj.org/toc/1663-9812Test
-
7دورية أكاديمية
المؤلفون: Frinchi M., Nuzzo D., Scaduto P., Di Carlo M., Massenti M. F., Belluardo N., Mudo G.
المساهمون: Frinchi M., Nuzzo D., Scaduto P., Di Carlo M., Massenti M.F., Belluardo N., Mudo G.
مصطلحات موضوعية: Oxotremorine, anti-inflammatory cytokines, Settore BIO/09 - Fisiologia
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31578381; info:eu-repo/semantics/altIdentifier/wos/WOS:000488482200015; volume:9; issue:1; firstpage:14233; numberofpages:16; journal:SCIENTIFIC REPORTS; http://hdl.handle.net/10447/381270Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85072935560; www.nature.com/srep/index.html
-
8دورية أكاديمية
المؤلفون: N. V. Avdeeva, Н. В. Авдеева
المصدر: Pharmacy & Pharmacology; Том 7, № 2 (2019); 84-89 ; Фармация и фармакология; Том 7, № 2 (2019); 84-89 ; 2413-2241 ; 2307-9266 ; 10.19163/2307-9266-2019-7-2
مصطلحات موضوعية: Леводопа, mGluR4, Rapitalam, Oxotremorine-induced tremor, Levodopa, Рапиталам, оксотреморин-индуцированный тремор
وصف الملف: application/pdf
العلاقة: https://www.pharmpharm.ru/jour/article/view/363/528Test; https://www.pharmpharm.ru/jour/article/view/363/529Test; Schapira, A.H.V. Neurobiology and treatment of Parkinson’s disease. // Trends Pharmacol. Sci. – 2009. – Vol. 30(1). – P. 41–47. DOI:10.1016/j.tips.2008.10.005.; Marino, M.J, Conn, P.J. Glutamate-based therapeutic approaches: allosteric modulators of metabotropic glutamate receptors. // Curr. Opin. Pharmacol. – 2006. – Vol. 6(1) – P. 98–102. DOI:10.1016/j.coph.2005.09.006.; Avdeeva, N.V., Nikitina, V.A., Kochkarova, I.S., Litvinova, A.S. The possibility of administration of glutamate receptors antagonists in the treatment of parkinson’s disease. // Research result: pharmacology and clinical pharmacology. – 2016. – Vol. 2(3). – Р. 86–94. DOI:10.18413/2500-235X-2016-2-3-86-94.; Avdeeva, N.V., Kulikov, A.L., Pokrovskii, M.V., Avtina, T.V. Pharmacokinetic studies of new antiparkinsonian drug Rapitalam. // Research result: pharmacology and clinical pharmacology. – 2016. – Vol. 2(4). – P. 3–8. DOI:10.18413/2500-235X-2016-2-4-3-8; Voronkov, A.V., Pozdnyakov, D.I. Endothelotropic activity of 4-hydroxy-3,5-di-tret-butylcinnamic acid in the conditions of experimental cerebral ischemia. // Research Results in Pharmacology. – 2018. – Vol. 4 (2). – Р. 1–10. DOI:10.3897/rrpharmacology.4.26519; Corti, C., Aldegheri, L., Somogyi, P., Ferraguti, F. Distribution and synaptic localisation of the metabotropic glutamate receptor 4 (mGluR4) in the rodent CNS. // Neuroscience. – 2002. – Vol. 110(3). – Р. 403–420. DOI:10.1016/S0306-4522(01)00591-7; Marino, M.J., Hess, J.F., Liverton, N. Targeting the metabotropic glutamate receptor mGluR4 for the treatment of diseases of the central nervous system. // Curr. Top. Med. Chem. – 2005. – Vol. 5(9). – Р. 885–895. DOI:10.2174/1568026054750263; Yang, Z.Q. Agonists and antagonists for group III metabotropic glutamate receptors 6, 7, and 8. // Curr. Top. Med. Chem. – 2005. – Vol. 5(9). – Р. 913–918. DOI:10.2174/1568026054750272; Johnson, K. A., Conn, P. J., and Niswender, C. M. Glutamate receptors astherapeutic targets for Parkinson’s disease. // CNS and Neurological Disorders. – 2009. – Vol. 8(6). – Р. 475–491. DOI:10.2174/187152709789824606; Hopkins, C.R., Lindsley, C.W., Niswender, C.M. mGluR4-positive allosteric modulation as potential treatment for Parkinson’s disease. // Future Med Chem. – 2009. – Vol. 1(3). – Р. 501–513. DOI:10.4155/fmc.09.38.mGluR4-positive; Wichmann, T., DeLong, M.R. Functional neuroanatomy of the basal ganglia in Parkinson’s disease. // Adv. Neurol. – 2003. – Vol. 91. – Р. 9–18.; Авдеева. Н.В., Сидорова. С.А., Поветкин. С.В., и др. Позитивная аллостерическая модуляция рецепторов mGluR4 как потенциальный подход к лечению болезни Паркинсона. // Известия высших учебных заведений. Медицинские науки. – 2018. – № 3. – С. 194–206.; Boraud, T., Bezard, E., Bioulac, B., Gross, C.E. From single extracellular unit recording in experimental and human parkinsonism to the development of a functional concept of the role played by the basal ganglia in motor control. // Prog. Neurobiol. – 2002. – Vol. 66(4). – Р. 265–283. DOI:10.1016/S0301-0082(01)00033-8; Conn, P,J., Pin, J.P.,. Pharmacology and functions of metabotropic glutamate receptors. // Ann. Rev. Pharmacol. Toxicol. – 1997. DOI: 37:205–237.10.1146/annurev.pharmtox.37.1.205; Dauer, W., Predborski, S. Parkinson’s disease: mechanisms and models. // Neuron. – 2003. – Vol. 39(6). – Р. 889–909. DOI:10.1016/S0896-6273(03)00568-3; Электронный ресурс, лекции белорусского государственного медицинского университета. https://studfiles.net/preview/6011051Test/; Pisani, A., Bernardi, G., Ding, J., Surmeier, D.J. Re-emergence of striatal cholinergic interneurons in movement disorders. // Trends Neurosci. – 2007. – Vol. 30. – Р. 545–553. DOI:10.1016/j.tins.2007.07.008; DiChiara, G., Morelli, M., Consolo, S. Modulatory functions of neurotransmitters in the striatum: ACh/ dopamine/NMDA interactions. // Trends Neurosci. – 1994. – Vol. 17(6). – Р. 228–233. DOI:10.1016/0166-2236(94)90005-1; Lester, D.B., Rogers, T.D., Blaha, C.D. Acetylcholinedopamine interactions in the pathophysiology and treatment of CNS disorders. // CNS Neurosci Ther. – 2010. – Vol. 16(13). – Р. 137–162. DOI:10.1111/j.1755-5949.2010.00142.x; https://www.pharmpharm.ru/jour/article/view/363Test
الإتاحة: https://doi.org/10.19163/2307-9266-2019-7-2-84-8910.19163/2307-9266-2019-7-210.1016/j.tips.2008.10.00510.1016/j.coph.2005.09.00610.18413/2500-235X-2016-2-3-86-9410.18413/2500-235X-2016-2-4-3-810.3897/rrpharmacology.4.2651910.1016/S0306-4522Test(01)00591-710.2174/156802605475026310.2174/156802605475027210.2174/18715270978982460610.4155/fmc.09.38.mGluR4-positive10.1016/S0301-0082(01)00033-810.1016/S0896-6273(03)00568-310.1016/j.tins.2007.07.00810.1016/0166-2236(94)90005-110.1111/j.1755-5949.2010.00142.x
https://www.pharmpharm.ru/jour/article/view/363Test -
9دورية أكاديمية
المؤلفون: Avdeeva, N. V.
مصطلحات موضوعية: medicine, pharmacology, parkinsons disease, mGluR4, rapitalam, oxotremorine-induced tremor, levodopa
العلاقة: Avdeeva, N.V. Study of rapitalam influence on oxotremorine-induced tremor / N.V. Avdeeva // Фармация и фармакология. - 2019. - Т.7, №2.-P. 84-89.; http://dspace.bsu.edu.ru/handle/123456789/31810Test
-
10
المؤلفون: Regan Ashby, Kate Thomson, Cindy Karouta, Ian G. Morgan, Tamsin Kelly
المصدر: British Journal of Pharmacology. 178:4501-4517
مصطلحات موضوعية: Atropine, Pharmacology, Muscarine, Carbachol, business.industry, Dopamine, Muscarinic Antagonists, Retina, eye diseases, chemistry.chemical_compound, Nicotinic agonist, chemistry, Muscarinic acetylcholine receptor, Myopia, medicine, Oxotremorine, Animals, Humans, Cholinergic, business, Chickens, Acetylcholine, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0608bf04ae7997074fe34b0eebfe111cTest
https://doi.org/10.1111/bph.15629Test